Application of TaqMan Array Cards for Identifying Causes of Acute Febrile Illness in Patients with Suspected Viral Hemorrhagic Fever - Summary - MDSpire

Application of TaqMan Array Cards for Identifying Causes of Acute Febrile Illness in Patients with Suspected Viral Hemorrhagic Fever

  • By

  • Gloria Grace Akurut

  • Luke Nyakarahuka

  • Shannon Whitmer

  • Dianah Namanya

  • Kilama Kamugisha

  • Sophia Mulei

  • Jimmy Baluku

  • Alex Tumusime

  • Jackson Kyondo

  • Ketan Patel

  • Julius J. Lutwama

  • Trevor Shoemaker

  • Joel Montgomery

  • John D. Klena

  • Stephen Balinandi

  • December 29, 2025

  • 0 min

Share

Objective:

To utilize TaqMan Array Cards (TAC) for the detection of alternative etiologies in patients with acute febrile illness (AFI) who tested negative for viral hemorrhagic fevers (VHF), highlighting the importance for public health.

Key Findings:
  • The AFI-TAC assay demonstrated a sensitivity of 88% and specificity of 99% when compared to individual PCR assays, which is crucial for timely treatment.
  • The study identified alternative pathogens in patients whose samples tested negative for VHF, aiding in differential diagnosis and improving treatment strategies.
Interpretation:

The use of TAC allows for rapid and accurate identification of multiple pathogens in AFI cases, which is crucial for timely public health interventions and improving patient outcomes.

Limitations:
  • The study relied on archived samples, which may not represent current pathogen prevalence and could introduce selection bias.
  • The TAC assay may not detect all possible pathogens due to its specific target configuration, potentially missing some etiologies.
Conclusion:

TaqMan Array Cards are effective for the rapid identification of multiple pathogens in acute febrile illnesses, enhancing diagnostic capabilities in resource-limited settings and supporting public health efforts.

Original Source(s)

Application of TaqMan Array Cards for Identifying Causes of Acute Febrile Illness in Patients with Suspected Viral Hemorrhagic Fever

  • by Gloria Grace Akurut, Luke Nyakarahuka, Shannon Whitmer, Dianah Namanya, Kilama Kamugisha, Sophia Mulei, Jimmy Baluku, Alex Tumusime, Jackson Kyondo, Ketan Patel, Julius J. Lutwama, Trevor Shoemaker, Joel Montgomery, John D. Klena, Stephen Balinandi

  • December 29, 2025

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Hospital-Treated Infections Linked to Dementia Risk

Investigators identify 29 conditions associated with dementia risk in nationwide registry analysis.

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.